RHÖN-KLINIKUM AG / Key word(s): Final Results/Investment
14-Feb-2017 / 15:17 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Bad Neustadt, February 14, 2017. The management board of RHÖN-KLINIKUM AG
decided in its today's meeting to conduct a technical value adjustment for
the financial year 2016 of approx. EUR 35.5 million in connection with the
financial investment in Marburger Ionenstrahl-Therapie Betriebsgesellschaft
des Universitätsklinikums Heidelberg mbH (MIT GmbH). The value adjustment
results from operational delays in connection with the initial operating
phase of the Marburg Ion Therapy Center. The resulting negative impact
affects the financial result and the consolidated result 2016 by a
corresponding amount. The medical potential of the system continues to be
promising for RHÖN-KLINIKUM AG and completes the service spectrum of the
Marburg site with regard to cancer therapy in a unique way. In this context
we are currently intensely working on an enlargement of the application
range towards further medical indications.
Your Contact
Dr. Kai G. Klinger (disclosing person)
Investor Relations & Corporate Finance
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1318
Telefax: +49 (0) 9771 99-1736
Email: ir@rhoen-klinikum-ag.com
Achim Struchholz
Communication
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1327
Telefax: +49 (0) 9771 65-1820
E-Mail: kommunikation@rhoen-klinikum-ag.com
14-Feb-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: RHÖN-KLINIKUM AG
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail: rka@rhoen-klinikum-ag.com
Internet: www.rhoen-klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard), Munich;
Regulated Unofficial Market in Berlin, Dusseldorf,
Hamburg, Stuttgart, Tradegate Exchange
End of Announcement DGAP News Service
Previous
Ad-hoc-News
| 02/14/2017